BerGenBio

About:

BerGenBio is clinical-stage biopharma developing first-in-class selective AXL kinase inhibitors to treat multiple aggressive cancers.

Website: http://www.bergenbio.com

Top Investors: Investinor, Sarsia Seed Management, Birk Venture, Meteva AS

Description:

BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers.